Correlation of human immunodeficiency virus type 1 RNA levels in blood and the female genital tract.
about
Contribution of immune activation to the pathogenesis and transmission of human immunodeficiency virus type 1 infectionLow pH immobilizes and kills human leukocytes and prevents transmission of cell-associated HIV in a mouse model.Compartmentalization of HIV-1 within the female genital tract is due to monotypic and low-diversity variants not distinct viral populations.Characterization of human immunodeficiency virus type 1 in saliva and blood plasma by V3-specific heteroduplex tracking assay and genotype analyses.Diversity, divergence, and evolution of cell-free human immunodeficiency virus type 1 in vaginal secretions and blood of chronically infected women: associations with immune status.Quantitation of human immunodeficiency virus type 1 RNA in different biological compartments.Detection and quantitation of human immunodeficiency virus type 1 in the female genital tract. The Division of AIDS Treatment Research Initiative 009 Study GroupQuantitation of human immunodeficiency virus type 1 (HIV-1) RNA in cell-free cervicovaginal secretions: comparison of reverse transcription-PCR amplification (AMPLICOR HIV-A MONITOR 1.5) with enhanced-sensitivity branched-DNA assay (Quantiplex 3.0)The effects of chronic binge alcohol on the genital microenvironment of simian immunodeficiency virus-infected female rhesus macaques.Treatment to prevent transmission of HIV-1HIV-1 genital shedding is suppressed in the setting of high genital antiretroviral drug concentrations throughout the menstrual cycle.Mother-to-child transmission of HIV infection in the era of highly active antiretroviral therapy.Real-time PCR quantification of genital shedding of herpes simplex virus (HSV) and human immunodeficiency virus (HIV) in women coinfected with HSV and HIV.Use of Sno Strip filter-paper wicks for collection of genital-tract samples allows reproducible determination of human immunodeficiency virus type 1 (HIV-1) RNA viral load with a commercial HIV-1 viral load assayPrevention of vaginal SHIV transmission in macaques by a coitally-dependent Truvada regimen.Oral transmission of HIV, reality or fiction? An update.Genital tract HIV RNA levels and their associations with human papillomavirus infection and risk of cervical precancer.Vaginal transmission of cell-associated HIV-1 in the mouse is blocked by a topical, membrane-modifying agent.In vitro evaluation of nonnucleoside reverse transcriptase inhibitors UC-781 and TMC120-R147681 as human immunodeficiency virus microbicides.Cervical shedding of HIV-1 RNA among women with low levels of viremia while receiving highly active antiretroviral therapyPlasma and cervical viral loads among Ugandan and Zimbabwean women during acute and early HIV-1 infection.HIV-1 RNA rectal shedding is reduced in men with low plasma HIV-1 RNA viral loads and is not enhanced by sexually transmitted bacterial infections of the rectum.Development of topical microbicides for prevention of human immunodeficiency virus and herpes simplex virus.Quantification of genital human immunodeficiency virus type 1 (HIV-1) DNA in specimens from women with low plasma HIV-1 RNA levels typical of HIV-1 nontransmitters.Prevalence and risk factors of cervicovaginal HIV shedding among HIV-1 and HIV-2 infected women in Dakar, Senegal.Antiretroviral therapy initiated soon after HIV diagnosis as standard care: potential to save lives?The role of sexually transmitted diseases in HIV transmission.Acute HIV revisited: new opportunities for treatment and prevention.Characterization of the Genital Microenvironment of Female Rhesus Macaques Prior to and After SIV InfectionDetection of infectious human immunodeficiency virus type 1 in female genital secretions by a short-term culture method.Comparison of techniques for HIV-1 RNA detection and quantitation in cervicovaginal secretions.Modelling the impact of antiretroviral therapy on the epidemic of HIVEvaluation of Performance Characteristics of the Aptima HIV-1 Quant Dx Assay for Detection and Quantitation of Human Immunodeficiency Virus Type 1 in Plasma and Cervicovaginal Lavage Samples.Can highly active antiretroviral therapy reduce the spread of HIV?: A study in a township of South Africa.Novel methodology for antiretroviral quantitation in the female genital tractTrichomonas vaginalis treatment reduces vaginal HIV-1 sheddingChanges in plasma viral load and penile viral shedding after circumcision among HIV-positive men in Kisumu, Kenya.Virologic and immunologic determinants of heterosexual transmission of human immunodeficiency virus type 1 in Africa.Prospects for antisense peptide nucleic acid (PNA) therapies for HIVVaginal HIV-1 shedding among HIV-1 infected women in the current era of combined antiretroviral therapy: A cross sectional study.
P2860
Q24550678-5E873C0E-3A82-40C0-959B-4EC9F316A371Q24815101-9FCF22F4-2B23-4239-88B0-48B198D7E86AQ33505667-22AC499B-33BE-4573-8C00-72EABBE5AC29Q33841640-7CE69B62-571C-4917-A759-06B190DFE247Q33908859-1793C2F0-8891-42C5-9732-CD02D6671996Q33966350-28B6E120-DC00-4D13-A683-76D5F6222373Q33970041-4429B6A2-53CC-44EC-A73F-68F5D8F97BC0Q33972457-8FE73568-DB75-4B2E-9C8C-CFA5B5E3CBC9Q33988160-ECDFEA00-582D-4DB0-B981-B971D0970AC3Q34102424-4101B566-A1F3-43E0-9361-A79BFE8FA658Q34366639-D6E59B97-BE0C-4E87-87E2-FD7EAE1C4DAFQ34387805-2582A127-6DB7-4446-8D56-2D1F5B71EAFDQ34430752-9152406A-05B6-460B-9207-279C61D06C5EQ34431853-B469577D-B1F1-4FC5-B5BB-DEEBFBB813E0Q34506545-FE9241C4-CF4F-4421-9137-E55112AD2386Q34526020-8D9C2E10-190D-4AC5-B543-4DC5B4C2FA6AQ34710212-AB586F69-2724-488F-A28F-67D43946E9D8Q34786887-B3B2DB1D-19DA-404A-8DAF-ABD766905BF4Q35006752-4D78BC6E-6FCB-4CFF-9365-6DA9AB2F65EBQ35077988-833B328B-9922-4A08-8B41-4F4CBA0B07B2Q35140678-B13BA0EC-9561-4137-A33A-FDE6E7396DDBQ35164471-A6B884C8-5BFA-4057-89EA-7D0BDC7DCED4Q35175233-5B1D3341-89DD-4522-9969-55F4576F1F3DQ35221103-13D50CFD-C354-4FE3-92D9-9D38CA59C08CQ35529313-7012FF87-725E-4DD4-9B1A-61DE67523D96Q35557314-2F9D1543-867C-46AA-9AFD-440FC2728015Q35701598-A287A47D-F8CC-4838-9620-16594EABE75FQ35730339-74AD6E54-B959-45DB-B3DB-CF940235D0E1Q35750861-0A5417D2-0022-4C87-8EE9-7CD87E3B1940Q35922038-DE4494F9-66B5-42DD-BEF1-3CF59E88CAB1Q36023811-870A5B0F-91D7-404D-B60B-731BD708C0D1Q36486234-71C34F2A-ABE9-4A29-A462-AE601AD64727Q36734872-1E11242D-73FA-4C64-B20F-59EA2B3616D7Q36849824-4D4531BC-C696-4862-903D-2A4D2E9810B5Q37158604-B7B1C2D2-D4ED-47FA-9733-841207C94DE5Q37188368-5A7671E6-7481-4633-A3CD-4D85A37EE11EQ37315596-8ADD8CD7-3585-4090-A966-73514735B0E9Q37357668-E0BF046E-DF43-4C90-BA6B-F556D21068A7Q37473797-E4C80EFF-C2F5-4A60-9E73-92C3C79AB11AQ37705397-AD65DAEF-6FC2-415C-B6D1-F6A39725AD19
P2860
Correlation of human immunodeficiency virus type 1 RNA levels in blood and the female genital tract.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh-hant
name
Correlation of human immunodef ...... and the female genital tract.
@en
Correlation of human immunodef ...... and the female genital tract.
@nl
type
label
Correlation of human immunodef ...... and the female genital tract.
@en
Correlation of human immunodef ...... and the female genital tract.
@nl
prefLabel
Correlation of human immunodef ...... and the female genital tract.
@en
Correlation of human immunodef ...... and the female genital tract.
@nl
P2093
P356
P1476
Correlation of human immunodef ...... and the female genital tract.
@en
P2093
Ellerbrock TV
Evans-Strickfaden T
Pratt-Palmore M
Schinazi RF
P304
P356
10.1086/314656
P407
P577
1999-04-01T00:00:00Z